Searched for
HAFFKINE INSTITUTE
Maharashtra FDA launches crackdown on food adulteration ahead of festive seasonMaharashtra FDA launched a state-wide inspection drive against food adulteration during the festive season, collecting over 2,300 samples, ...
NCP slams Eknath Shinde Government over Nanded tragedyNationalist Congress Party (NCP) Working President Supriya Sule on Tuesday slammed the Eknath Shinde-led Shiv Sena Government over the deat...
Maharashtra Medical Crisis: 24, including 12 infants, die at Nanded government hospital in 24 hoursThe incident was reported at Shankarao Chavan Government Medical College and Hospital here due to the alleged scarcity of medicines. Dr Shy...
"No shortage of medicine": Nanded Hospital Dean denies medical negligence as cause of deaths of 24 patientsOn Tuesday, Congress chief Mallikarjun Kharge called for a detailed investigation into the case saying the incident was "extremely painful,...
Pharma Inc sets sights on monkeypox vaxPune-based Serum Institute of India , Reliance Life Sciences, Dr Reddy's Laboratories, Biological E and two state-owned units - Mumbai-base...
Covaxin output may hit 100 million doses per month by November“For Covaxin, we will see a significant (production) ramp-up of more than double in August-September, when the doses manufactured by Bharat...
Why it is not that easy for other vaccine makers to just start producing CovaxinExplaining the need for a BSL-3 facility to make Covaxin, Dr Rakesh K Mishra, former director and now advisor of Centre for Cellular and Mo...
Reports of delay in licensing for Covaxin 'factually incorrect': Govt"There have been reports in a section of the media followed by some uninformed tweets alleging delay in licensing for Covaxin and delayed a...
Apply the law to accelerate Covaxin output: India has enough legal provisions to make it happen, say expertsBharat Biotech had issued a statement saying, “Capacity expansion has been implemented across multiple facilities... to reach 700 million d...
Govt aims for 6-7 crore Covaxin doses/month by July-AugustThe state-run Public Sector Undertaking (PSUs) will manufacture the drug on the basis of transfer of technology. “The government of India w...
Haffkine Institute gets nod to produce CovaxinThe Maharashtra government had sought permission from the centre in March seeking the Centre’s nod in getting Haffkine to have a deal with ...
PM meet: Maharashtra CM seeks more vaccination centres, Haffkine nodMaharashtra Chief Minister Uddhav Thackeray on Wednesday sought approval for starting more vaccination centres to expedite inoculation in t...
Maharashtra plans clinical trials of TB vaccine BCG to treat Covid-19The 121-year-old institute’s trial is intended for patients who are moderately ill with Covid-19 and is likely to be carried out in small b...
With Covid-19 count at 32, Maharashtra expands healthcare facilitiesMaharashtra has reported 32 positive cases of novel coronavirus so far. Health Minister Rajesh Tope assured people that new laboratories wi...
Homoeopathy research showcase at World Summit may spell new hope for HIV, tuberculosis patientsIn a pioneering two-year long study, city-based homoeopath Dr Rajesh Shah has developed a new medicine for AIDS patients, sourced from huma...
Indian-origin professor awarded Fulbright-Nehru fellowshipKulkarni is a professor in the Department of Surgery at The University of Texas Health Science Center at Houston (UTHealth) Medical School.
Government okays advanced, Rs 450 crore cancer therapy centreApart from the Hadron Therapy Centre, a cancer hospital for children and women would be developed as part of the project.
- Tata Hospital to get five-acre Haffkine Institute land
Maharashtra Cabinet today approved a proposal to allot five acres of land owned by the Haffkine Institute to Tata Memorial Hospital to buil...
7-month-old is Mumbai's third swine flu victimA seven-month-old girl died of swine flu here on Tuesday, becoming the third casualty of the disease in the metropolis.
- Government leaves vaccine space for private companies
The government has decided not to revive the four state-owned vaccine units whose licences were recently suspended.